Literature DB >> 8461762

ACE inhibitors after myocardial infarction.

M K Vannan, D J Taylor, M M Webb-Peploe, M A Konstam.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8461762      PMCID： PMC1677196          DOI： 10.1136/bmj.306.6877.531

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Ventricular remodelling after myocardial infarction.

Authors:  M A Vannan; D J Taylor
Journal:  Br Heart J       Date:  1992-09

2.  Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction.

Authors:  M A Pfeffer; G A Lamas; D E Vaughan; A F Parisi; E Braunwald
Journal:  N Engl J Med       Date:  1988-07-14       Impact factor: 91.245

3.  Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition.

Authors:  N Sharpe; H Smith; J Murphy; S Greaves; H Hart; G Gamble
Journal:  Lancet       Date:  1991-04-13       Impact factor: 79.321

4.  [Sar1]angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells.

Authors:  J F Aceto; K M Baker
Journal:  Am J Physiol       Date:  1990-03

5.  Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.

Authors:  M A Pfeffer; J M Pfeffer; C Steinberg; P Finn
Journal:  Circulation       Date:  1985-08       Impact factor: 29.690

6.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

7.  Changes in cardiac angiotensin converting enzyme after myocardial infarction and hypertrophy in rats.

Authors:  C I Johnston; V Mooser; Y Sun; B Fabris
Journal:  Clin Exp Pharmacol Physiol       Date:  1991-02       Impact factor: 2.557

8.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.

Authors:  S Yusuf; B Pitt; C E Davis; W B Hood; J N Cohn
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

Review 9.  Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.

Authors:  K T Weber; C G Brilla
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

10.  Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

Authors:  K Swedberg; P Held; J Kjekshus; K Rasmussen; L Rydén; H Wedel
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245
  10 in total
  4 in total

1.  ACE inhibitors after myocardial infarction.

Authors:  K Swedberg; J Kjekshus
Journal:  BMJ       Date:  1993-04-03

2.  ACE inhibitors after myocardial infarction.

Authors:  A S Hall; L B Tan; S G Ball
Journal:  BMJ       Date:  1993-04-03

3.  Haemodynamic interactions of a new calcium sensitizing drug levosimendan and captopril.

Authors:  S Antila; J Eha; M Heinpalu; L Lehtonen; I Loogna; A Mesikepp; U Planken; E P Sandell
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

4.  Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods.

Authors:  A M Choy; D Darbar; C C Lang; T H Pringle; G P McNeill; N S Kennedy; A D Struthers
Journal:  Br Heart J       Date:  1994-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.